Aclaris Therapeutics, Inc. · NASDAQ:ACRS

BlackRock, Inc. reported a 5.10% stake in Aclaris Therapeutics, Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Jul 17, 2025

BlackRock, Inc. reported a 5.10% stake in Aclaris Therapeutics, Inc., 5,471,711 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G).

Stake
5.10%
Shares
5,471,711
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
BlackRock, Inc.5.10%5,471,711

Source

View original at SEC

Related